4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000056
Chief Financial Officer sold 25,760 shares at $29.62 ($763,011)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Girao Tiago Chief Financial Officer | 2026-04-23 | Sale | −25,760 | $29.62 | $763,011 | 247,596 | D |
| Open-market sales · 25,760 sh · avg $29.62 · $763,011 | |||||||
Loading xslF345X06/wk-form4_1777061232.xml…